Feed ARHCF
AR

Alfresa Holdings Corporation

ARHCF · OTC

$14.00 +0.00% (+$0.00)
Market Cap ¥390.1B
P/E Ratio 14.24x
Div. Yield 3.17%
ROE -

Bulios Fair Price

$16.86

20.4% upside

Current Price

$14

Undervalued Fair Value Overvalued

According to Bulios Fair Price, ARHCF is currently undervalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Moderate
6/9
Valuation
96 /100
Cheap
P/S 0.13x
P/E 14.24x
P/B 0.81x
Growth
32 /100
Declining
Book val. growth 0.72%
EPS growth 1.33%
Rev. growth 4.62%
Profitability
5 /100
Weak
Op. margin 1.29%
Gross margin 7.22%
FCF margin 0.49%
Quality
40 /100
Average
Asset turnover 2.06x
ROIC 4.86%
ROA 1.90%
Debt
93 /100
Low
Int. coverage 142.07x
Debt/Equity 0.07x
Net debt/EBITDA -2.59x
Stability
72 /100
Stable
EPS volatility 19.33%
Beta 0.08x
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about ARHCF
Online

Sector

Healthcare

Industry

Medical - Distribution

CEO

Ryuji Arakawa

Employees

12,525

Headquarters

Tokyo

Upcoming events

29 SEP

Ex-Dividend

Ex-dividend date

4d
29 SEP

Dividend Payment

Payment date

4d
05 NOV

Earnings

Upcoming earnings report

41d
31 MAR

Ex-Dividend

Ex-dividend date

187d
31 MAR

Dividend Payment

Payment date

187d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.